Greenjoules Raises Rs 150 Cr Series B Led by Amazon Funds
Pune-based renewable fuels startup Greenjoules has raised Rs 150 crore in a Series B co-led by Amazon's Smbhav Venture Fund and Climate Pledge Fund.
Pune-based renewable fuels startup Greenjoules has raised Rs 150 crore (about 1.5 billion rupees) in a Series B round co-led by Amazon's Smbhav Venture Fund and the Climate Pledge Fund.
The round also drew participation from Rainmatter, the investment arm of Zerodha, and from Singularity's Strategic Autonomy Fund. Blue Ashva Capital, which led Greenjoules' Series A in 2021, remains the company's largest shareholder.
Rs 100 crore loan on top
Separately, the startup has secured a Rs 100 crore loan from the Technology Development Board (TDB), which operates under the Department of Science and Technology. Together, the equity round and the loan give Greenjoules Rs 250 crore in fresh financing.
Why it matters
The deal pairs private climate-focused capital with state-backed debt, a combination that signals continued interest in India's renewable fuels sector. Amazon's two funds co-leading the round also gives the company a notable corporate backer, while Blue Ashva's position as top shareholder shows that its early investors are staying on board.
The company has said the combined financing will support its growth plans.
Apps worth a look
Tap the right tiles, add them up, hit the target. Easy to learn, hard to master. Free, for all ages.
Talk to an AI conversation partner; every sentence comes back corrected and explained in your language. 9 languages, A1 to C2.
Open EDIFACT and X12 messages, see every segment explained, convert to JSON/XML, export PDF and Excel. Runs locally, no upload.
Pick who it is for, the occasion and their personality. The search engine reads product descriptions from local shops and ranks what fits. Free, no sign-up.
More from this day
See all →
OpenAI Acquires AI Travel Assistant Odessia, Hires Founder

Simya VC Holds First Demo Day on Industrial AI in Istanbul

India reopens PLI scheme for medical devices, extends it to 2035-36


